SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-22-143660
Filing Date
2022-05-06
Accepted
2022-05-06 16:15:57
Documents
2
Group Members
ALBERT CHAFHMLS X, L.L.C.FHMLS X, L.P.FHMLSP, L.L.C.FHMLSP, L.P.FRAZIER LIFE SCIENCES X, L.P.JAMES BRUSHJAMES N. TOPPERPATRICK J. HERON

Document Format Files

Seq Description Document Type Size
1 SC 13D d310572dsc13d.htm SC 13D 244956
2 EX-A d310572dex99a.htm EX-99.A 17172
  Complete submission text file 0001193125-22-143660.txt   263962
Mailing Address TWO UNION SQUARE, 601 UNION ST. SUITE 3200 SEATTLE WA 98101
Business Address TWO UNION SQUARE, 601 UNION ST. SUITE 3200 SEATTLE WA 98101 650-325-5156
Frazier Life Sciences Public Fund, L.P. (Filed by) CIK: 0001863769 (see all company filings)

IRS No.: 862999645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 75 STATE ST. SUITE 100 BOSTON MA 02109
Business Address 75 STATE ST. SUITE 100 BOSTON MA 02109 (617) 213-5054
HilleVax, Inc. (Subject) CIK: 0001888012 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93640 | Film No.: 22901255
SIC: 2836 Biological Products, (No Diagnostic Substances)